• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性乙型肝炎中LAG-3表达增加会抑制T细胞功能:免疫强度与肝损伤程度之间的平衡。

Increasing LAG-3 expression suppresses T-cell function in chronic hepatitis B: A balance between immunity strength and liver injury extent.

作者信息

Ye Bo, Li Xuefen, Dong Yuejiao, Wang Yiyin, Tian Li, Lin Sha, Liu Xia, Kong Haishen, Chen Yu

机构信息

Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province, Department of Laboratory Medicine, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, PR China.

出版信息

Medicine (Baltimore). 2017 Jan;96(1):e5275. doi: 10.1097/MD.0000000000005275.

DOI:10.1097/MD.0000000000005275
PMID:28072682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5228642/
Abstract

Weak or absent virus-specific CD8 T-cell responses to hepatitis B virus (HBV) infection are thought to be responsible for persistent HBV infection. Previous studies have indicated that multiple inhibitory receptors, including lymphocyte activation gene-3 (LAG-3), can suppress the CD8 T-cell response in chronic viral infection. This study aimed to detect LAG-3 expression and to investigate the manner in which the immune response is regulated to balance the strength of the response with the extent of liver injury in chronic HBV infection. The results showed that LAG-3 expression levels were significantly higher in CD8 T cells from chronic hepatitis B patients in the immune-active phase compared with chronic asymptomatic HBV carriers and healthy controls. CD8 T-cell function was suppressed in cells with high LAG-3 expression, and these cells exhibited reduced interferon-γ (IFN-γ) secretion. Furthermore, IFN-γ secretion was restored in CD8 T cells that were treated with a specific antibody to LAG-3. Taken together, liver injury was prominent in the immune-active phase, but suppressing T-cell function could mitigate this damage. Importantly, the inhibitory function of LAG-3 can be blocked using a LAG-3-specific antibody, and this can restore the activity of non-functional T cells.

摘要

对乙型肝炎病毒(HBV)感染的病毒特异性CD8 T细胞反应较弱或缺失被认为是导致HBV持续感染的原因。先前的研究表明,包括淋巴细胞活化基因3(LAG-3)在内的多种抑制性受体可在慢性病毒感染中抑制CD8 T细胞反应。本研究旨在检测LAG-3的表达,并研究在慢性HBV感染中免疫反应是如何被调节以平衡反应强度与肝损伤程度的。结果显示,与慢性无症状HBV携带者及健康对照相比,免疫活动期慢性乙型肝炎患者的CD8 T细胞中LAG-3表达水平显著更高。LAG-3高表达的细胞中CD8 T细胞功能受到抑制,且这些细胞的干扰素-γ(IFN-γ)分泌减少。此外,用LAG-3特异性抗体处理的CD8 T细胞中IFN-γ分泌得以恢复。综上所述,肝损伤在免疫活动期较为突出,但抑制T细胞功能可减轻这种损伤。重要的是,使用LAG-3特异性抗体可阻断LAG-3的抑制功能,且这可恢复无功能T细胞的活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/5228642/0c7418980ff3/medi-96-e5275-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/5228642/5a5acc503fd8/medi-96-e5275-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/5228642/2cea8aa3fbb8/medi-96-e5275-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/5228642/de2f803847f7/medi-96-e5275-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/5228642/83e198a2fad2/medi-96-e5275-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/5228642/0c7418980ff3/medi-96-e5275-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/5228642/5a5acc503fd8/medi-96-e5275-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/5228642/2cea8aa3fbb8/medi-96-e5275-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/5228642/de2f803847f7/medi-96-e5275-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/5228642/83e198a2fad2/medi-96-e5275-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/5228642/0c7418980ff3/medi-96-e5275-g006.jpg

相似文献

1
Increasing LAG-3 expression suppresses T-cell function in chronic hepatitis B: A balance between immunity strength and liver injury extent.慢性乙型肝炎中LAG-3表达增加会抑制T细胞功能:免疫强度与肝损伤程度之间的平衡。
Medicine (Baltimore). 2017 Jan;96(1):e5275. doi: 10.1097/MD.0000000000005275.
2
[Elevated expression of lymphocyte activation gene-3 on peripheral blood CD8(+) T lymphocytes in patients with chronic hepatitis B virus infection].[慢性乙型肝炎病毒感染患者外周血CD8(+) T淋巴细胞上淋巴细胞激活基因-3的表达升高]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Apr;32(4):532-7.
3
The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function.CD244 在慢性乙型肝炎感染中的免疫调节作用及其对病毒特异性 CD8+ T 细胞功能的抑制潜力。
Hepatology. 2010 Dec;52(6):1934-47. doi: 10.1002/hep.23936. Epub 2010 Nov 9.
4
CD4 T cell exhaustion revealed by high PD-1 and LAG-3 expression and the loss of helper T cell function in chronic hepatitis B.慢性乙型肝炎中高表达 PD-1 和 LAG-3、辅助性 T 细胞功能丧失导致的 CD4 T 细胞耗竭。
BMC Immunol. 2019 Aug 7;20(1):27. doi: 10.1186/s12865-019-0309-9.
5
T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance.慢性乙型肝炎感染中的T细胞耗竭:当前认知与临床意义
Cell Death Dis. 2015 Mar 19;6(3):e1694. doi: 10.1038/cddis.2015.42.
6
Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.病毒特异性CD8 T细胞的动态程序性死亡1表达与急性乙型肝炎的转归相关。
Gastroenterology. 2008 Jun;134(7):1938-49, 1949.e1-3. doi: 10.1053/j.gastro.2008.03.037. Epub 2008 Mar 22.
7
Lymphocyte activation gene 3 negatively regulates the function of intrahepatic hepatitis C virus-specific CD8+ T cells.淋巴细胞激活基因3负向调节肝内丙型肝炎病毒特异性CD8 + T细胞的功能。
J Gastroenterol Hepatol. 2015 Dec;30(12):1788-95. doi: 10.1111/jgh.13017.
8
Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.白细胞介素-35 在慢性乙型肝炎病毒感染中抑制抗病毒免疫反应。
Front Cell Infect Microbiol. 2017 Nov 13;7:472. doi: 10.3389/fcimb.2017.00472. eCollection 2017.
9
Type I Interferon Signaling Prevents Hepatitis B Virus-Specific T Cell Responses by Reducing Antigen Expression.I 型干扰素信号通过降低抗原表达来阻止乙型肝炎病毒特异性 T 细胞应答。
J Virol. 2018 Nov 12;92(23). doi: 10.1128/JVI.01099-18. Print 2018 Dec 1.
10
Hepatic expansion of virus-specific CD8BTLA T cells with regulatory properties in chronic hepatitis B virus infection.慢性乙型肝炎病毒感染中具有调节特性的病毒特异性CD8⁺BTLA⁺ T细胞在肝脏中的扩增
Cell Immunol. 2017 Jan;311:36-45. doi: 10.1016/j.cellimm.2016.10.002. Epub 2016 Oct 6.

引用本文的文献

1
Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC.肿瘤相关巨噬细胞和 CD8+ T 细胞:HBV 相关 HCC 发病机制中的双重作用者。
Front Immunol. 2024 Oct 10;15:1472430. doi: 10.3389/fimmu.2024.1472430. eCollection 2024.
2
Insights into Immune Exhaustion in Chronic Hepatitis B: A Review of Checkpoint Receptor Expression.慢性乙型肝炎免疫耗竭的研究进展:检查点受体表达综述
Pharmaceuticals (Basel). 2024 Jul 21;17(7):964. doi: 10.3390/ph17070964.
3
Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective.

本文引用的文献

1
Hepatitis B virus infection.乙型肝炎病毒感染。
Lancet. 2014 Dec 6;384(9959):2053-63. doi: 10.1016/S0140-6736(14)60220-8. Epub 2014 Jun 18.
2
CTLA-4 and its ligands on the surface of T- and B-lymphocyte subsets in chronic hepatitis B virus infection.慢性乙型肝炎病毒感染中T淋巴细胞和B淋巴细胞亚群表面的CTLA-4及其配体。
J Med Assoc Thai. 2013 Jan;96 Suppl 1:S54-9.
3
Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8(+) T cell in HCC patients.LAG-3 的表达与 HBV 特异性 CD8(+) T 细胞在 HCC 患者中的效应功能障碍一致。
利用自然杀伤细胞治疗难治性/复发性非霍奇金淋巴瘤:生物学作用、临床试验及未来展望
Biomark Res. 2024 Jul 17;12(1):66. doi: 10.1186/s40364-024-00610-z.
4
Dynamic immune signatures of patients with advanced non-small-cell lung cancer for infection prediction after immunotherapy.免疫治疗后预测晚期非小细胞肺癌患者感染的动态免疫特征。
Front Immunol. 2024 Jan 26;15:1269253. doi: 10.3389/fimmu.2024.1269253. eCollection 2024.
5
Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity.慢性乙型肝炎病毒感染的免疫反应和治疗靶点:固有和适应性免疫。
Front Cell Infect Microbiol. 2023 Jun 22;13:1206720. doi: 10.3389/fcimb.2023.1206720. eCollection 2023.
6
Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma.肿瘤微环境中 LAG-3 与 CD8 的免疫组化评分可预测肝细胞癌对免疫治疗的反应。
Front Immunol. 2023 Jun 5;14:1150985. doi: 10.3389/fimmu.2023.1150985. eCollection 2023.
7
PIK3C2A is a prognostic biomarker that is linked to immune infiltrates in kidney renal clear cell carcinoma.PIK3C2A 是一种预后生物标志物,与肾透明细胞癌中的免疫浸润有关。
Front Immunol. 2023 Mar 30;14:1114572. doi: 10.3389/fimmu.2023.1114572. eCollection 2023.
8
Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation.HBV 感染背景下的 T 细胞和 NK 细胞免疫检查点:全景、病理生理学和治疗开发。
Front Immunol. 2023 Mar 28;14:1148111. doi: 10.3389/fimmu.2023.1148111. eCollection 2023.
9
Hepatitis B functional cure and immune response.乙型肝炎的功能性治愈和免疫反应。
Front Immunol. 2022 Nov 17;13:1075916. doi: 10.3389/fimmu.2022.1075916. eCollection 2022.
10
The relationship between soluble lymphocyte activation gene-3 and coronary artery disease.可溶性淋巴细胞激活基因-3与冠状动脉疾病的关系。
Front Cardiovasc Med. 2022 Sep 29;9:988582. doi: 10.3389/fcvm.2022.988582. eCollection 2022.
Immunol Lett. 2013 Feb;150(1-2):116-22. doi: 10.1016/j.imlet.2012.12.004. Epub 2012 Dec 20.
4
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape.免疫抑制分子 LAG-3 和 PD-1 协同调节 T 细胞功能,促进肿瘤免疫逃逸。
Cancer Res. 2012 Feb 15;72(4):917-27. doi: 10.1158/0008-5472.CAN-11-1620. Epub 2011 Dec 20.
5
T cell exhaustion.T 细胞耗竭。
Nat Immunol. 2011 Jun;12(6):492-9. doi: 10.1038/ni.2035.
6
The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function.CD244 在慢性乙型肝炎感染中的免疫调节作用及其对病毒特异性 CD8+ T 细胞功能的抑制潜力。
Hepatology. 2010 Dec;52(6):1934-47. doi: 10.1002/hep.23936. Epub 2010 Nov 9.
7
Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.肿瘤浸润性 NY-ESO-1 特异性 CD8+ T 细胞在人卵巢癌中受 LAG-3 和 PD-1 的负调控。
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7875-80. doi: 10.1073/pnas.1003345107. Epub 2010 Apr 12.
8
Pathogenesis of hepatitis B virus infection.乙型肝炎病毒感染的发病机制。
Pathol Biol (Paris). 2010 Aug;58(4):258-66. doi: 10.1016/j.patbio.2009.11.001. Epub 2010 Feb 8.
9
How chronic viral infections impact on antigen-specific T-cell responses.慢性病毒感染如何影响抗原特异性 T 细胞应答。
Eur J Immunol. 2010 Mar;40(3):654-63. doi: 10.1002/eji.200940102.
10
On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection.在急性和慢性 LCMV 感染中抑制性受体 LAG-3 的作用。
Int Immunol. 2010 Jan;22(1):13-23. doi: 10.1093/intimm/dxp107. Epub 2009 Oct 30.